The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
CGG repeat in the FMR1 gene: size matters
Open accessAbstract
The FMR1 gene contains a CGG repeat present in the 5'-untranslated region which can be unstable upon transmission to the next generation. The repeat is up to 55 CGGs long in the normal population. In patients with fragile X syndrome (FXS), a repeat length exceeding 200 CGGs (full mutation: FM) generally leads to methylation of the repeat and the promoter region, which is accompanied by silencing of the FMR1 gene. The absence of FMR1 protein, FMRP, seen in FM is the cause of the mental retardation in patients with FXS. The premutation (PM) is defined as 55-200 CGGs. Female PM carriers are at risk of developing primary ovarian insufficiency. Elderly PM carriers might develop a progressive neurodegenerative disorder called fragile X-associated tremor/ataxia syndrome (FXTAS). Although arising from the mutations in the same gene, distinct mechanisms lead to FXS (absence of FMRP), FXTAS (toxic RNA gain-of-function) and FXPOI. The pathogenic mechanisms thought to underlie these disorders are discussed. This review gives insight on the implications of all possible repeat length categories seen in fragile X families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP is highly expressed in the brain and acts as translational repressor of several signaling pathways at the synaptic level (Willemsen et al. 2011).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Willemsen et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Incidence of Premature Ovarian Failure
Coulam, C. B., Adamson, S. C., & Annegers, J. F. (1987) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198703000-00020 · Cited by 1,024
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Hagerman, R. J., Leehey, M. A., Heinrichs, W. L., Tassone, F., Wilson, R., Hills, J. D., Grigsby, J., Gage, B. F., & Hagerman, P. J. (2001) · Neurology · doi:10.1212/wnl.57.1.127 · Cited by 966
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952
Fragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M. A., Kremer, E. J., Lynch, M., Nancarrow, J. K., Baker, E. G., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 793
Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Jacquemont, S., Hagerman, R. J., Leehey, M. A., Grigsby, J., Zhang, L., Brunberg, J. A., Greco, C., Portes, V. D., Jardini, T., Levine, R. A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/374321 · Cited by 761
Cited by
Sorted by citations
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Reddy, K., Zamiri, B., Stanley, S. Y., Macgregor, R. B., & Pearson, C. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.452532 · Cited by 318
Dendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 266
Sequencing the unsequenceable: Expanded CGG-repeat alleles of the fragile X genePreprint
Loomis, E. W., Eid, J. S., Peluso, P. S., Yin, J., Hickey, L., Rank, D. R., McCalmon, S. A., Hagerman, R. J., Tassone, F., & Hagerman, P. J. (2012) · Genome Research · doi:10.1101/gr.141705.112 · Cited by 203
The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease
Roberts, T. C., Morris, K. V., & Wood, M. J. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0507 · Cited by 213
Dendritic spine dysgenesis in autism related disorders
Phillips, M. L., & Pozzo‐Miller, L. D. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.011 · Cited by 188
A Wide Extent of Inter-Strain Diversity in Virulent and Vaccine Strains of Alphaherpesviruses
SZPARA, M. L., Tafuri, Y. R., Parsons, L. R., Shamim, S. R., Verstrepen, K. J., Legendre, M., & Enquist, L. W. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002282 · Cited by 157
Primary ovarian insufficiency: an update
LIU, J. H., & Cox, L. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s37636 · Cited by 166
Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex
Kwan, K. Y., Lam, M. M. S., Johnson, M. B., Dube, U., Shim, S., Rašin, M.-R., Sousa, A. M. M., Fertuzinhos, S., Chen, J.-G., Arellano, J. I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.060 · Cited by 137
Self-citationCurrent Concepts in Premature Ovarian Insufficiency
Maclaran, K., & Panay, N. (2015) · Women s Health · doi:10.2217/whe.14.82 · Cited by 135
Analysis of somatic microsatellite indels identifies driver events in human tumors
Maruvka, Y. E., Mouw, K. W., Karlić, R., Parasuraman, P., Kamburov, A., Polak, P. P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 126
Maiti, P., Manna, J., Ilavazhagan, G., Rossignol, J., & Dunbar, G. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.020 · Cited by 128
Structural variation in 1,019 diverse humans based on long-read sequencing
Schloissnig, S., Pani, S., Ebler, J., Hain, C., Tsapalou, V., Söylev, A., Hüther, P., Ashraf, H., Prodanov, T., Asparuhova, M., et al. (2025) · Nature · doi:10.1038/s41586-025-09290-7 · Cited by 141
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Eshraghi, M., Karunadharma, P. P., Blin, J., Shahani, N., Ricci, E. P., Michel, A. M., Urban, N. T., Galli, N., Sharma, M., Ramírez-Jarquín, U. N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21637-y · Cited by 114
The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells
Gerhardt, J., Tomishima, M. J., Zaninović, N., Colak, D., Yan, Z., Zhan, Q., Rosenwaks, Z., Jaffrey, S. R., & Schildkraut, C. L. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.029 · Cited by 104
Identification of rare de novo epigenetic variations in congenital disorders
Barbosa, M., Joshi, R. S., Garg, P., Martin-Trujillo, A., Patel, N., Jadhav, B., Watson, C. T., Gibson, W. T., Chetnik, K., Tessereau, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04540-x · Cited by 101
Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice
Gantois, I., Pop, A. S., de Esch, C. E. F., Buijsen, R. A. M., Pooters, T., Gomez-Mancilla, B., Gasparini, F., Oostra, B. A., D’Hooge, R., & Willemsen, R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.059 · Cited by 100
Self-citationAlterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome
Jawaid, S., Kidd, G. J., Wang, J., Swetlik, C., Dutta, R., & Trapp, B. D. (2017) · Glia · doi:10.1002/glia.23284 · Cited by 93
Buijsen, R. A. M., Visser, J. A., Kramer, P. F., Severijnen, E., Gearing, M., Charlet‐Berguerand, N., Sherman, S. L., Berman, R. F., Willemsen, R., & Hukema, R. K. (2015) · Human Reproduction · doi:10.1093/humrep/dev280 · Cited by 95
Self-citationFragile X Syndrome: The FMR1 CGG Repeat Distribution Among World Populations
Peprah, E. K. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00694.x · Cited by 96
Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS
Killoran, A., Biglan, K., Jankovic, J. J., Eberly, S. W., Kayson, E., Oakes, D., Young, A. B., & Shoulson, I. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b304 · Cited by 104
Zerbi, V., Ielacqua, G. D., Markicevic, M., Haberl, M. G., Ellisman, M. H., A-Bhaskaran, A., Frick, A., Rudin, M., & Wenderoth, N. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy046 · Cited by 81
Clark, C., Palta, P., Joyce, C. J., Scott, C., Grundberg, E., Deloukas, P., Palotie, A. V., & Coffey, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050233 · Cited by 94
Murray, A., Schoemaker, M. J., Bennett, C. E., Ennis, S., Macpherson, J., Jones, M. E., Morris, D. H., Orr, N., Ashworth, A., Jacobs, P. A., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.64 · Cited by 93
Biancalana, V., Glaeser, D., McQuaid, S., & Steinbach, P. J. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.185 · Cited by 97
Buijsen, R. A. M., Sellier, C., Severijnen, L.-A. W. F. M., Oulad‐Abdelghani, M., Verhagen, R. F. M., Berman, R. F., Charlet‐Berguerand, N., Willemsen, R., & Hukema, R. K. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0162-2 · Cited by 84
Self-citationMechanism-Based Treatments in Neurodevelopmental Disorders: Fragile X Syndrome
Berry‐Kravis, E. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.001 · Cited by 86
Hafford‐Tear, N. J., Tsai, Y., Sadan, A. N., Sanchez-Pintado, B., Zarouchlioti, C., Maher, G. J., Lišková, P., Tuft, S. J., Hardcastle, A. J., Clark, T. A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0453-x · Cited by 77
Zongaro, S., Hukema, R. K., D’Antoni, S., Davidovic, L., Barbry, P., Catania, M. V., Willemsen, R., Mari, B. P., & Bardoni, B. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt044 · Cited by 78
Self-citationMouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
Berman, R. F., Buijsen, R. A. M., Usdin, K., Pintado, E., Kooy, R. F., Pretto, D. I., Pessah, I. N., Nelson, D. L., Zalewski, Z. A., Charlet‐Berguerand, N., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-25 · Cited by 76
Self-citationBerman, R. F., Murray, K. D., Arqué, G., Hunsaker, M. R., & Wenzel, H. J. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03486.x · Cited by 64
Fragile X syndrome and fragile X-associated tremor ataxia syndrome
Hall, D. A., & Berry‐Kravis, E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00025-7 · Cited by 65
Fragile X Screening by Quantification of FMRP in Dried Blood Spots by a Luminex Immunoassay
LaFauci, G., Adayev, T., Kascsak, R. J., Kascsak, R., Nolin, S. L., Mehta, P. D., Brown, W. T., & Dobkin, C. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.02.006 · Cited by 56
Repeat-associated non-AUG (RAN) translation: insights from pathology
Báñez-Coronel, M., & Ranum, L. P. W. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0241-x · Cited by 56
Induced expression of expanded CGG RNA causes mitochondrial dysfunctionin vivo
Hukema, R. K., Buijsen, R. A. M., Raske, C., Severijnen, L.-A. W. F. M., Nieuwenhuizen‐Bakker, I., Minneboo, M., Maas, A., de Crom, R., Kros, J. M., Hagerman, P. J., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.943112 · Cited by 54
Self-citationKraan, C. M., Hocking, D. R., Bradshaw, J. L., Fielding, J., Cohen, J., Georgiou‐Karistianis, N., & Cornish, K. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.010 · Cited by 53
Davis, J. M., Searles, V. B., Anderson, N., Keeney, J., Dumas, L., & Sikela, J. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004241 · Cited by 51
DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome
Nobile, V., Pucci, C., Chiurazzi, P., Neri, G., & Tabolacci, E. (2021) · Biomolecules · doi:10.3390/biom11020296 · Cited by 48
Cis-acting DNA sequence at a replication origin promotes repeat expansion to fragile X full mutation
Gerhardt, J., Zaninović, N., Zhan, Q., Madireddy, A., Nolin, S. L., Ersalesi, N., Yan, Z., Rosenwaks, Z., & Schildkraut, C. L. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201404157 · Cited by 45
Epigenetic mechanisms of gene expression regulation in neurological diseases
Goś, M. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1919 · Cited by 45
The Genetics of C9orf72 ExpansionsPreprint
Gijselinck, I., Cruts, M., & Broeckhoven, C. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026757 · Cited by 43
Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene
Barasoain, M., Barrenetxea, G., Huerta, I., Télez, M., Criado, M. B., & Arrieta, I. (2016) · Genes · doi:10.3390/genes7120123 · Cited by 45
Yang, J., Niu, Y., Simon, C., Seritan, A. L., Chen, L., Schneider, A., Moghaddam, S. T., Hagerman, P. J., Hagerman, R. J., & Olichney, J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.122 · Cited by 42
The multiple molecular facets of fragile X-associated tremor/ataxia syndrome
Sellier, C., Usdin, K., Pastori, C., Peschansky, V. J., Tassone, F., & Charlet‐Berguerand, N. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-23 · Cited by 42
Kidd, S. A., Berry‐Kravis, E., Choo, T. H., Chen, C., Esler, A., Hoffmann, A., Andrews, H., & Kaufmann, W. E. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04148-0 · Cited by 41
Lack of RAN-mediated toxicity in Huntington’s disease knock-in mice
Yang, S., Yang, H., Huang, L., Chen, L., Qin, Z. S., Li, S., & Li, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919197117 · Cited by 37
Perturbation of dendritic protrusions in intellectual disability
Levenga, J., & Willemsen, R. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00008-x · Cited by 38
Self-citationVoorhuis, M., Onland‐Moret, N. C., Janse, F., van Amstel, H. K. P., Goverde, A. J., Lambalk, C. B., Laven, J. S. E., van der Schouw, Y. T., Broekmans, F. J., Fauser, B. C. J. M., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu095 · Cited by 37
Genetics of androgen metabolism in women with infertility and hypoandrogenism
Shohat-Tal, A., Sen, A., Barad, D. H., Kushnir, V. A., & Gleicher, N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.64 · Cited by 37
Yang, J., Chan, S.-H., Khan, S., Schneider, A., Nanakul, R., Teichholtz, S., Niu, Y., Seritan, A. L., Tassone, F., Grigsby, J., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs251 · Cited by 32
Mbadiwe, T., & Millis, R. M. (2013) · Autism Research and Treatment · doi:10.1155/2013/826156 · Cited by 37
Selective spatial processing deficits in an at-risk subgroup of the fragile X premutation
Hocking, D. R., Kogan, C. S., & Cornish, K. M. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2012.02.005 · Cited by 32
Zhao, X.-N., & Usdin, K. (2013) · Human Mutation · doi:10.1002/humu.22495 · Cited by 31
Fragile X premutation and associated health conditions: A review
Tassanakijpanich, N., Hagerman, R. J., & Worachotekamjorn, J. (2021) · Clinical Genetics · doi:10.1111/cge.13924 · Cited by 30
Borel, C., Migliavacca, E., Letourneau, A., Gagnebin, M., Béna, F., Sailani, M. R., Dermitzakis, E. T., Sharp, A. J., & Antonarakis, S. E. (2012) · Human Mutation · doi:10.1002/humu.22115 · Cited by 29
MicroRNA expression profiling in blood from fragile X‐associated tremor/ataxia syndrome patients
Álvarez‐Mora, M. I., Rodríguez‐Revenga, L., Madrigal, I., Torres‐Silva, F., Mateu-Huertas, E., Lizano, E., Friedländer, M. R., Martı́, E., Estivill, X., & Milà, M. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12061 · Cited by 33
Phenotypes of hypofrontality in older female fragile X premutation carriers
Yang, J.-C., Simon, C., Niu, Y., Bogost, M. D., Schneider, A., Tassone, F., Seritan, A. L., Grigsby, J., Hagerman, P. J., Hagerman, R. J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23933 · Cited by 29
Weghofer, A., Tea, M., Barad, D. H., Kim, A., Singer, C. F., Wagner, K., & Gleicher, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044753 · Cited by 28
Brykczynska, U., Pecho‐Vrieseling, E., Thiemeyer, A., Klein, J. L., Fruh, I., Doll, T., Manneville, C., Fuchs, S., Iazeolla, M., Beibel, M., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.10.004 · Cited by 28
Current Gaps in Understanding the Molecular Basis of FXTAS
Hagerman, P. J. (2011) · PubMed Central · doi:10.7916/d80c4th0 · Cited by 27
The Impact in Older Women of Ovarian FMR1 Genotypes and Sub-Genotypes on Ovarian Reserve
Gleicher, N., Weghofer, A., Kim, A., & Barad, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033638 · Cited by 27
Zerbi, V., Markicevic, M., Gasparini, F., Schroeter, A., Rudin, M., & Wenderoth, N. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.051 · Cited by 25
Early decline in functional ovarian reserve in young women with low (CGGn < 26) FMR1 gene alleles
Gleicher, N., Yu, Y., Himaya, E., Barad, D. H., Weghofer, A., Wu, Y.-G., Albertini, D. F., Wang, V. Q., & Kushnir, V. A. (2015) · Translational research · doi:10.1016/j.trsl.2015.06.014 · Cited by 26
Brasa, S., Mueller, A., Jacquemont, S., Hahne, F., Rozenberg, I., Peters, T., He, Y., McCormack, C., Gasparini, F., Chibout, S., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0181-x · Cited by 24
Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series
Debrey, S. M., Leehey, M. A., Klepitskaya, O., Filley, C. M., Shah, R. C., Kluger, B. M., Berry‐Kravis, E., Spector, E., Tassone, F., & Hall, D. A. (2016) · The Cerebellum · doi:10.1007/s12311-016-0809-6 · Cited by 24
Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer
Murmann, A. E., Yu, J., Opal, P., & Peter, M. E. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.08.004 · Cited by 25
Non-Mendelian inheritance patterns and extreme deviation rates of CGG repeats in autismPreprint
Annear, D. J., Vandeweyer, G., Sanchis‐Juan, A., Raymond, F. L., & Kooy, R. F. (2022) · Genome Research · doi:10.1101/gr.277011.122 · Cited by 22
Effects of AFQ056 on language learning in fragile X syndrome
Berry‐Kravis, E., Abbeduto, L., Hagerman, R. J., Coffey, C. S., Cudkowicz, M., Erickson, C. A., McDuffie, A. S., Hessl, D. R., Ethridge, L. E., Tassone, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171723 · Cited by 24
Zeidler, S., de Boer, H., Hukema, R. K., & Willemsen, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00368 · Cited by 23
Self-citationShelton, A. L., Cornish, K. M., Godler, D. E., Clough, M., Kraan, C. M., Bui, M., & Fielding, J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.011 · Cited by 20
Li, J., Sakata, A., He, H., Bai, L., Murata, A., Dohno, C., & Nakatani, K. (2016) · Chemistry - An Asian Journal · doi:10.1002/asia.201600527 · Cited by 19
Klein, C. J., & Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000000440 · Cited by 20
Expanded complexity of unstable repeat diseases
Polak, U., McIvor, E., Dent, S., Wells, R. D., & Напиерала, М. (2012) · BioFactors · doi:10.1002/biof.1060 · Cited by 19
Grzybowska, E. A., & Wakuła, M. (2021) · Cells · doi:10.3390/cells10112910 · Cited by 17
Communication in fragile X syndrome: Patterns and implications for assessment and intervention
Hoffmann, A. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.929379 · Cited by 18
Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat
Ferder, I. C., Parborell, F., Sundblad, V., Chiauzzi, V. A., Gómez, K. A., Charreau, E. H., Tesone, M., & Daín, L. (2013) · Reproduction · doi:10.1530/rep-12-0305 · Cited by 18
Kurosaki, T., & Ashizawa, T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.936869 · Cited by 17
Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model
Zeidler, S., Pop, A. S., Jaafar, I. A., de Boer, H., Buijsen, R. A. M., de Esch, C. E. F., Nieuwenhuizen‐Bakker, I., Hukema, R. K., & Willemsen, R. (2018) · Brain and Behavior · doi:10.1002/brb3.991 · Cited by 17
Self-citationhnRNP Q Regulates Internal Ribosome Entry Site-Mediated fmr1 Translation in Neurons
Choi, J., Kim, S., Jeong, Y.-H., Kim, S. W., Min, K., & Kim, K. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00371-18 · Cited by 14
Gerhardt, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.004 · Cited by 15
Lachiewicz, A. M., Stackhouse, T. M., Burgess, K. M., Burgess, D., Andrews, H., Choo, T.-H. J., Kaufmann, W. E., & Kidd, S. A. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06135-y · Cited by 14
Kodavati, M. M., Rao, V. H. M., Provasek, V. E., & Hegde, M. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102413 · Cited by 15
Tosh, D., Rao, K. L., Rani, H. S., Deenadayal, D. A., Murty, U. S. N., & Grover, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3145-4 · Cited by 14
Rajan‐Babu, I., & Chong, S. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9213-3_14 · Cited by 13
Lieb-Lundell, C. (2016) · Physical Therapy · doi:10.2522/ptj.20140430 · Cited by 13
Álvarez‐Mora, M. I., Rodríguez‐Revenga, L., Madrigal, I., Garcia‐García, F., Durán, M., Dopazo, J., Estivill, X., & Milà, M. (2015) · Gene · doi:10.1016/j.gene.2015.06.039 · Cited by 13
FMR1, circadian genes and depression: suggestive associations or false discovery?
Kripke, D. F., Nievergelt, C. M., Tranah, G. J., Murray, S. S., Rex, K. M., Grizas, A. P., Hahn, E. K., Lee, H., Kelsoe, J. R., & Kline, L. E. (2013) · Journal of Circadian Rhythms · doi:10.1186/1740-3391-11-3 · Cited by 12
Janz, P., Bainier, M., Marashli, S., Gross, S., & Redondo, R. L. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110182 · Cited by 11
Remmers, C. L., & Contractor, A. (2018) · eNeuro · doi:10.1523/eneuro.0137-18.2018 · Cited by 10
Juang, B.-T., Ludwig, A. L., Benedetti, K. L., Gu, C., Collins, K., Morales, C., Asundi, A., Wittmann, T., L’Étoile, N. D., & Hagerman, P. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu210 · Cited by 10
X‐linked neuronal migration disorders: Gender differences and insights for genetic screening
Edey, J., Soleimani‐Nouri, P., Dawson‐Kavanagh, A., Azeem, M. S. I., & Episkopou, V. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10290 · Cited by 10
Autism spectrum disorder genetics; a comprehensive review
Mashayekhi, F., & Salehi, Z. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0040 · Cited by 11
Lin, Y., Xue, J., Deng, J., He, H., Luo, S., Chen, J., Li, J., Yu, L. F., Zhao, J., Chen, J., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105013 · Cited by 9
Fragile X Syndrome in a Female With Homozygous Full-Mutation Alleles of the FMR1 Gene
Vafaeie, F., Alerasool, M., Mojaver, N. K., & Mojarrad, M. (2021) · Cureus · doi:10.7759/cureus.16340 · Cited by 9
Satange, R., Rode, A. B., & Hou, M. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117094 · Cited by 10
Montanaro, F. A. M., Alfieri, P., & Vicari, S. (2023) · Brain Sciences · doi:10.3390/brainsci13020277 · Cited by 9
341 Repeats Is Not Enough for Methylation in a New Fragile X Mouse Model
Colvin, S. M., Lea, N., Zhang, Q., Wienisch, M., Kaiser, T., Aida, T., & Feng, G. (2022) · eNeuro · doi:10.1523/eneuro.0142-22.2022 · Cited by 9
Nabariya, D. K., Heinz, A., Derksen, S., & Krauß, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1000932 · Cited by 9
Disassociation between brain activation and executive function in fragile X premutation females
Shelton, A. L., Cornish, K. M., Clough, M., Gajamange, S. I., Kolbe, S., & Fielding, J. (2016) · Human Brain Mapping · doi:10.1002/hbm.23438 · Cited by 8
Metadata
- Authors
- Willemsen, R., Levenga, J., & Oostra, B.
- Affiliations
- Erasmus MC (NL)
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2011-06-30
- Volume
- 80
- Issue
- 3
- Pages
- 214-225
- ISSN
- 0009-9163 (ISSN-L)
- PMC
- PMC3151325
- OpenAlex
- W2122400358
- Cited by
- 184
- References
- 114
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 12 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 12 · 2018: 12 · 2017: 8 · 2016: 16 · 2015: 11 · 2014: 22 · 2013: 20 · 2012: 17
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Genetics (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- ZonMw (113301069)
- National Institute of Neurological Disorders and Stroke (RL1NS062411)
- National Institute of Dental and Craniofacial Research (UL1DE019583)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD38038, R01HD038038)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- FMR1 gene, CGG repeat, fragile X syndrome, fragile X premutation, fragile X-associated tremor/ataxia syndrome, repeat length, repeat instability, DNA methylation, FMRP, neurodegeneration, pathophysiological mechanisms
- MeSH terms
- Aged, Animals, Ataxia, Brain, Disease Models, Animal, Female, Fragile X Syndrome, Genotype, Humans, Neurons, Phenotype, Gene Expression, Primary Ovarian Insufficiency, Mice, Knockout, Trinucleotide Repeats, DNA Methylation, 5' Untranslated Regions, Mice, Fragile X Messenger Ribonucleoprotein 1, Prescription Drugs, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review